Royalty Pharma

RPRX13F as of Jun 30, 2026 · next update ~Nov 14

Who's buying RPRX

Top funds mostly trimmed Royalty Pharma in Q2 (Apr⁠–⁠Jun)

Buying:

FundsInsidersCongress

Top funds
1 of 3 bought more, 2 sold some. Largest: Patient Capital Management, $201.8M (7% of its portfolio).
Insiders
No buys, 38 sales in 12 months.
Congress
No trades disclosed in the last 12 months.

3 funds$373.3M held6.8% avg. weightQ2: 1 bought / 2 sold

13F reports are a snapshot as of Jun 30, 2026; funds may have traded since. Insiders often sell for personal reasons (taxes, diversification, planned sales).

Share price · market data, not from 13F reports

Q2 2026

Insider trades (Form 4)

Last 2 years · 39 filings

Date	Insider	Type	Shares	Price	Value
Oct 5, 2026	Marshall Urist VP	Sold	4,126	$57.10	$236K
Sep 28, 2026	Marshall Urist VP	Sold	4,126	$57.88	$239K
Sep 22, 2026	Christopher Hite VP & Chair	Sold	100,000	$58.53	$5.85M
Aug 18, 2026	Christopher Hite VP & Chair	Sold	100,000	$59.97	$6.00M
Aug 13, 2026	Terrance P. Coyne VP & CFO	Sold	11,002	$58.68	$646K
Jul 1, 2026	Marshall Urist VP	Sold	9,099	$55.88	$508K
Jun 30, 2026	Christopher Hite VP & Chair	Sold	130,000	$56.50	$7.35M
Jun 24, 2026	Marshall Urist VP	Sold	9,098	$55.18	$502K
Jun 23, 2026	Christopher Hite VP & Chair	Sold	150,000	$54.40	$8.16M
May 26, 2026	Terrance P. Coyne VP & CFO	Sold	64,399	$53.98	$3.48M
May 20, 2026	Marshall Urist VP	Sold	13,684	$52.75	$722K
May 14, 2026	Marshall Urist VP	Sold	13,684	$53.06	$726K
May 14, 2026	Gregory Norden Director	Sold	3,045	$53.00	$161K
Apr 28, 2026	Terrance P. Coyne VP & CFO	Sold	34,791	$49.78	$1.73M
Apr 1, 2026	Terrance P. Coyne VP & CFO	Sold	34,791	$48.33	$1.68M
Mar 23, 2026	Terrance P. Coyne VP & CFO	Sold	34,791	$45.53	$1.58M
Mar 2, 2026	Terrance P. Coyne VP & CFO	Sold	34,791	$46.78	$1.63M
Feb 23, 2026	Terrance P. Coyne VP & CFO	Sold	34,791	$45.32	$1.58M
Feb 2, 2026	Terrance P. Coyne VP & CFO	Sold	243,541	$42.54	$10.36M
Jan 30, 2026	Marshall Urist VP	Sold	20,000	$41.09	$822K
Jan 23, 2026	Marshall Urist VP	Sold	20,000	$40.26	$805K
Jan 20, 2026	Terrance P. Coyne VP & CFO	Sold	69,582	$39.35	$2.74M
Jan 16, 2026	Marshall Urist VP	Sold	20,000	$39.52	$790K
Jan 9, 2026	Marshall Urist VP	Sold	20,000	$40.78	$816K
Jan 2, 2026	Terrance P. Coyne VP & CFO	Sold	69,582	$38.42	$2.67M
Jan 2, 2026	Marshall Urist VP	Sold	20,000	$38.48	$770K
Dec 26, 2025	Marshall Urist VP	Sold	20,000	$39.32	$786K
Dec 19, 2025	Marshall Urist VP	Sold	20,000	$38.38	$768K
Dec 17, 2025	George W. Lloyd VP & CLO	Sold	110,000	$38.55	$4.24M
Dec 16, 2025	Marshall Urist VP	Sold	20,000	$38.32	$766K
Dec 15, 2025	Terrance P. Coyne VP & CFO	Sold	69,582	$38.36	$2.67M
Dec 5, 2025	Marshall Urist VP	Sold	41,576	$39.15	$1.63M
Dec 3, 2025	George W. Lloyd VP & CLO	Sold	110,000	$39.77	$4.38M
Dec 1, 2025	Terrance P. Coyne VP & CFO	Sold	69,582	$39.87	$2.77M
Dec 1, 2025	Marshall Urist VP	Sold	41,575	$39.92	$1.66M
Nov 24, 2025	Terrance P. Coyne VP & CFO	Sold	69,582	$38.55	$2.68M
Nov 19, 2025	George W. Lloyd VP & CLO	Sold	135,426	$38.34	$5.19M
Nov 17, 2025	Terrance P. Coyne VP & CFO	Sold	69,594	$39.30	$2.74M
Aug 11, 2025	Gregory Norden Director	Sold	33,500	$36.23	$1.21M